Physician

Quasir Raza, MD

According to 2025 Medicare claims, Quasir Raza, MD (NPI: 1497846943) practices internal medicine in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is LEWIS GALE PHYSICIANS LLC (NPI: 1902977705; TIN: 061755234) and primary practice location at 24019-4028.

Raza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,233 traditional Medicare patients, billed 8,223 HCPCS/CPT codes, and received $456,173 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 26,625 prescription claims across 1,260 beneficiaries totaling $2,578,616 in drug costs, led by Eliquis (Apixaban). DME data shows 1,189 claims. Open Payments data shows 69 records totaling $1,234. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,018,502 to $2,578,616. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $21,059 to $61,181.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,225	6,661	$290,753
2016	1,160	7,297	$318,461
2017	1,245	7,694	$375,678
2018	1,224	7,951	$383,472
2019	1,442	8,691	$411,167
2020	1,353	8,212	$396,956
2021	1,249	8,580	$469,177
2022	1,299	7,579	$417,931
2023	1,153	7,110	$427,968
2024	1,233	8,223	$456,173

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	743	17,098	$1,018,502
2016	780	18,512	$1,064,740
2017	824	19,769	$1,216,237
2018	873	19,104	$1,270,102
2019	958	20,048	$1,377,921
2020	1,005	22,056	$1,599,415
2021	1,079	23,263	$1,874,306
2022	1,070	23,166	$2,194,645
2023	1,197	25,054	$2,706,992
2024	1,260	26,625	$2,578,616

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	198	741	$20,979
2016	204	725	$16,989
2017	197	651	$13,612
2018	249	893	$21,893
2019	333	1,055	$43,309
2020	336	1,215	$61,542
2021	474	1,575	$81,053
2022	440	1,497	$85,338
2023	358	1,372	$76,417
2024	323	1,189	$61,740

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	544	544	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	483	782	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	598	1,554	$63
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	368	2,194	$59
G0444	Annual depression screening, 5 to 15 minutes	351	351	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	464	25,622	$495,419
Farxiga	Dapagliflozin Propanediol	166	7,886	$137,848
Ozempic	Semaglutide	111	4,287	$130,482
Jardiance	Empagliflozin	131	6,849	$126,139
Xarelto	Rivaroxaban	124	5,754	$107,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	58	$19,146
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	14	89	$6,450
A7030	Full face mask used with positive airway pressure device, each	N	22	63	$4,724
A7031	Face mask interface, replacement for full face mask, each	N	20	59	$4,705
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	27	77	$2,602

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,234	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Quasir Raza, MD?

Tedicare shows public-source Medicare data for Quasir Raza, MD (NPI 1497846943), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Quasir Raza, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Quasir Raza, MD?

Quasir Raza, MD is linked to LEWIS GALE PHYSICIANS LLC (billing NPI 1902977705) in the available physician profile data.

Does Quasir Raza, MD have Open Payments data?

Quasir Raza, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.